Search Results - "A. M. Pevzner"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Human papillomavirus and lung cancer: an overview and a meta-analysis by Tsyganov, M. M., Pevzner, A. M., Ibragimova, M. K., Deryusheva, I. V., Litviakov, N. V.

    “…Purpose This review is devoted to assessing the prevalence of human papillomavirus (HPV) in lung cancer (LC) in the world. HPV is recognized as the etiological…”
    Get full text
    Journal Article
  2. 2

    In vitro modeling of tumor interclonal interactions using breast cancer cell lines by Bychkov, V A, Pevzner, A M, Nebova, J A, Ermakova, N N, Ibragimova, M K, Tsyganov, M M, Lyapunova, L S, Litviakov, N V

    Published in Experimental oncology (01-06-2021)
    “…To study the peculiarities of ecological relationships of breast cancer (BC) cell lines MCF-7, BT-474 and MDA-MD-231 under co-culturing conditions. Three BC…”
    Get more information
    Journal Article
  3. 3

    Human papillomavirus in head and neck cancer (literature review) by Pevzner, A. M., Tsyganov, M. M., Ibragimova, M. K., Litvyakov, N. V.

    Published in Opukholi golovy i shei (02-07-2019)
    “…This review is devoted to assessing the prevalence of human papillomavirus (HPV) in head and neck tumors (HNC). HPV is recognized as the etiological factor of…”
    Get full text
    Journal Article
  4. 4

    LOSS OF HETEROZYGOSITY IN THE BRCA1 AND BRCA2 LOCUS IN BREAST CANCER by Tsyganov, M. M., Ibragimova, M. K., Pevzner, A. M., Litviakov, N. V.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (06-07-2020)
    “…One of the factors of variability of malignant neoplasms is the loss of heterozygosity (LOH). The biological meaning of LOH, in relation to carcinogenesis, is…”
    Get full text
    Journal Article
  5. 5

    PARP1 inhibitors in breast cancer therapy. Mechanism of action and clinical use by Dolgasheva, D. S., Pevzner, A. M., Ibragimova, M. K., Litvyakov, N. V., Tsyganov, M. M.

    Published in Opukholi zhenskoĭ reproduktivnoĭ sistemy (09-06-2020)
    “…It is known that currently PARP inhibitors are actively used in the treatment of tumors of the female reproductive system. A large number of studies have been…”
    Get full text
    Journal Article
  6. 6

    STUDY OF THE HUMAN PAPILLOMA VIRUS PREVALENCE AND ITS PHYSICAL STATUS IN PATIENS WITH NON-SMALL CELL LUNG CANCER by Ibragimova, M. K., Tsyganov, M. M., Pevzner, A. M., Rodionov, E. O., Cheremisina, O. V., Miller, S. V., Tuzikov, S. A., Litviakov, N. V.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (02-05-2021)
    “…To date, the role of human papillomavirus (HpV) in the development of lung cancer is still under investigation. The available published data do not provide…”
    Get full text
    Journal Article
  7. 7

    Gene expression analysis of ABC transporter family in breast tumors: relationship with chemotherapy effect and disease prognosis by Tsyganov, M. M., Ibragimova, M. K., Pevzner, A. M., Gaptulbarova, K. A., Garbukov, E. Yu, Slonimskaya, Е. М., Usynin, E. A., Litviakov, N. V.

    Published in Uspehi molekulârnoj onkologii (06-09-2020)
    “…Background. One of the main reasons of the ineffectiveness of chemotherapy is still considered to be the formation of the multidrug resistance phenotype of the…”
    Get full text
    Journal Article
  8. 8

    The prognostic significance of BRCA1 gene expression in patients with breast cancer by Tsyganov, M. M., Ibragimova, M. K., Pevzner, A. M., Garbukov, E. Yu, Slonimskaya, E. M., Litviakov, N. V.

    Published in Uspehi molekulârnoj onkologii (27-07-2019)
    “…Background . Nowadays, BRCA-associated breast cancer occupies a special position in the choice of treatment strategy. Although, the drug treatment of such…”
    Get full text
    Journal Article
  9. 9

    RESPONSE TO NEOADYAVANT CHEMOTHERAPY WITH PLATINUM-BASED DRUGS IN BREAST CANCER PATIENTS WITH BRCA1 DELETION IN TUMOR by Tsyganov, M. M., Tarabanovskaya, N. A., Deryusheva, I. V., Ibragimova, M. K., Kazantseva, P. V., Pevzner, A. M., Slonimskaya, E. M., Litviakov, N. V.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (30-06-2019)
    “…Currently, the presence of the germinal mutation BRCA1 5382insC in breast cancer patients is one of the determining factors for prescribing platinum-based…”
    Get full text
    Journal Article
  10. 10

    Efficiency in different immunotherapy of cancer: literature review by K. A. Gaptulbarova, M. M. Tsyganov, M. K. Ibragimova, A. M. Pevzner, L. V. Spirina, N. V. Litviakov

    Published in Uspehi molekulârnoj onkologii (01-12-2021)
    “…It is known that the immune system plays one of the main roles in the development of oncology. This is confirmed by the fact that patients with congenital or…”
    Get full text
    Journal Article
  11. 11

    Late Cenozoic sequences of mammalian sites in Eurasia: an updated correlation by Fejfar, Oldrich, Heinrich, Wolf-Dieter, Pevzner, M.A., Vangengeim, E.A.

    “…A review of the geochronological sequence of Late Cenozoic mammalian sites in Eurasia covering the time span from the Vallesian up to the Toringian is given…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15